Correlation of fetal hemoglobin in different cancer patients and sickle cell anaemia: A review
1 Department of Pharmaceuticals sciences and Technology, Birla Institute of technology, Mesa, India.
2 Department of Biochemistry, Hazara University, Mansehra, Pakistan.
Review Article
World Journal of Advanced Research and Reviews, 2021, 12(01), 396–400
Publication history:
Received on 25 August 2021; revised on 21 October 2021; accepted on 23 October 2021
Abstract:
Fetal hemoglobin is the main hemoglobin during gestation period. But this globin chain is replaced and is taken over by adult hemoglobin. Sometimes this switch from fetal to adult fails to occur leading to production of fetal hemoglobin as in case of sickle cell anemia. It is also observed that fetal hemoglobin expression is also seen under malignant condition. In malignancy the spleen, liver as well as gut acquire its ability to produce fetal hemoglobin. Certain HbF cells inducing factor such as stem cell growth factor and interleukin -3 also promote HbF erythropoiesis. HbF cells are indicated as a biomarker of tumour cells implicated in many carcinomas observed by immunohisto chemical investigations.
Keywords:
Fetal hemoglobin; DNA methylation; Hematopoeisis; F cells
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0